Table 1.
Demographics, clinical characteristics of patients with COVID-19.
| Demographics and clinical characteristics | Number (%) |
|---|---|
| Number of patients | 337 |
| Age (years), median (IQR) | 44 (34–55) |
| ≤ 19 | 5 (1.5) |
| 20–34 | 80 (23.7) |
| 35–49 | 127 (37.7) |
| 50–64 | 108 (32.0) |
| ≥65 | 17 (5.1) |
| Gender | |
| Female | 183 (54.3) |
| Male | 154 (45.7) |
| Classification | |
| Mild | 19 (5.6) |
| Moderate | 318 (94.4) |
| The onset of symptom to hospital admission (days), median (IQR) | 10 (7–15) |
| ≤ 7 | 106 (31.5) |
| 8–14 | 115 (34.1) |
| ≥15 | 79 (23.4) |
| Unknown | 37 (11.0) |
| Hospital stay (days), median (IQR) | 17 (15–19) |
| ≤ 7 | 9 (2.7) |
| 8–14 | 73 (21.6) |
| 15–21 | 241 (71.5) |
| ≥22 | 14 (4.2) |
| Comorbidities | |
| Hypertension | 14 (4.2) |
| Chronic lung disease | 12 (3.6) |
| Endocrine system disease (including diabetes) | 8 (2.4) |
| Cardiovascular disease | 2 (0.6) |
| Cerebrovascular disease | 2 (0.6) |
| Chronic kidney disease | 2 (0.6) |
| Digestive system disease | 3 (0.9) |
| History of tumor surgery | 2 (0.6) |
| Others | 3 (0.9) |